脂质外壳组成对全氟化碳纳米液滴稳定缩小尺寸起关键作用
本研究探讨改变脂质外壳组成对全氟化碳纳米液滴(PFCnDs)尺寸及超声/光声(US/PA)成像性能的影响。结果显示,提高PEG化脂质的摩尔百分比可减小PFCnDs的尺寸和尺寸方差,且含更多PEG化脂质的纳米液滴比标准配方产生更强的US/PA信号;该方法在小鼠乳腺癌模型中实现了US/PA成像。
要点
- 提高PEG化脂质摩尔百分比可减小PFCnDs尺寸和尺寸方差。
- 含更多PEG化脂质的纳米液滴比标准配方产生更强的US/PA信号。
- 该方法在小鼠乳腺癌模型中实现了US/PA成像。
核心结论
- 通过简便合成工艺,提高PEG化脂质摩尔百分比可制备单分散、小尺寸的PFCnDs,并增强US/PA信号,可能促进PFCnDs在更广泛用户群中研究各种血管外现象。
研究设计与样本
- 本研究为实验研究,研究变量为脂质外壳组成;评估指标为PFCnDs尺寸及US/PA图像特性;并在小鼠乳腺癌模型中验证US/PA成像能力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Perfluorocarbon nanodroplets (PFCnDs) are phase-change contrast agents that have the potential to enable extravascular contrast-enhanced ultrasound and photoacoustic (US/PA) imaging. Producing consistently small, monodisperse PFCnDs remains a challenge without resorting to technically challenging methods. We investigated the impact of variable shell composition on PFCnD size and US/PA image properties. Our results suggest that increasing the molar percentage of PEGylated lipid reduces the size and size variance of PFCnDs. Furthermore, our imaging studies revealed that nanodroplets with more PEGylated lipids produce increased US/PA signal compared with those with the standard formulation. Finally, we highlight the ability of this approach to facilitate US/PA imaging in a murine model of breast cancer. These data indicate that, through a facile synthesis process, it is possible to produce monodisperse, small-sized PFCnDs. Novel in their simplicity, these methods may promote the use of PFCnDs among a broader user base to study a variety of extravascular phenomena.
引用
- Yarmoska SK, Yoon H, Emelianov SY, et al. Lipid Shell Composition Plays a Critical Role in the Stable Size Reduction of Perfluorocarbon Nanodroplets. Ultrasound Med Biol. 2019. PMID: 30975536. doi:10.1016/j.ultrasmedbio.2019.02.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。